20 March 2017 |

Innogest invests in MedLumics, €34m Series B Round closed

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today the largest round in the history of medtech in Spain and one of the largest in Europe this year. Led by Edmond de Rothschild Investment Partners (EdRIP), the Series B round included funding from new investors Seroba Life Sciences, Innogest Capital, as well as from existing investors Ysios Capital Partners and Caixa Capital Risc